Because the free/total (f/t PSA) ratio appears to be most clinically useful when PSA reaches levels of 4 to 10 ng/mL, detecting the free/total (f/t PSA) ratio can improve the specificity in monitoring prostate cancer and decrease the number of negative biopsies in patients. Here, KLK3 is linked to prostate carcinoma.